JP2022540585A5 - - Google Patents

Info

Publication number
JP2022540585A5
JP2022540585A5 JP2022500797A JP2022500797A JP2022540585A5 JP 2022540585 A5 JP2022540585 A5 JP 2022540585A5 JP 2022500797 A JP2022500797 A JP 2022500797A JP 2022500797 A JP2022500797 A JP 2022500797A JP 2022540585 A5 JP2022540585 A5 JP 2022540585A5
Authority
JP
Japan
Prior art keywords
methyl
oxy
biphenyl
pentyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022500797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050968 external-priority patent/WO2021007662A1/en
Publication of JP2022540585A publication Critical patent/JP2022540585A/ja
Publication of JP2022540585A5 publication Critical patent/JP2022540585A5/ja
Pending legal-status Critical Current

Links

JP2022500797A 2019-07-12 2020-07-10 カンナビノイド誘導体 Pending JP2022540585A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962873562P 2019-07-12 2019-07-12
US62/873,562 2019-07-12
US201962934937P 2019-11-13 2019-11-13
US62/934,937 2019-11-13
PCT/CA2020/050968 WO2021007662A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022540585A JP2022540585A (ja) 2022-09-16
JP2022540585A5 true JP2022540585A5 (enExample) 2023-07-13

Family

ID=74209626

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500797A Pending JP2022540585A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12252503B2 (enExample)
EP (1) EP3997098A4 (enExample)
JP (1) JP2022540585A (enExample)
WO (1) WO2021007662A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
CN113666958A (zh) * 2020-05-13 2021-11-19 成都百裕制药股份有限公司 大麻素衍生物及其制备方法和在医药上的应用
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
WO2022213931A1 (zh) * 2021-04-06 2022-10-13 山东绿叶制药有限公司 大麻二酚前药及其药物组合物和应用
CN116253671B (zh) * 2021-12-10 2025-07-04 德义制药有限公司 一种大麻二酚衍生物及其制备方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE431085B (sv) 1977-09-13 1984-01-16 Pfizer 3-(2-hydroxi-4-(substituerade)fenyl)cykloalkanoner och -cykloalkanoder och vissa derivat derav till anvendning for farmakologiska och medicinska endamal
US4391827A (en) 1980-09-08 1983-07-05 Pfizer Inc. 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US5205852A (en) * 1991-11-12 1993-04-27 Imperial Chemical Industries Plc Alkylphosphonamidate herbicides
CN101253184B (zh) 2005-09-14 2011-06-15 大八化学工业株式会社 磷化合物及其用途和阻燃聚酯纤维
JP4716954B2 (ja) 2006-08-17 2011-07-06 富士フイルム株式会社 ｏ−ビフェニルジフェニルホスフェートおよびトリフェニルホスフェートの混合物の製造方法。
PT2473475T (pt) 2009-08-31 2017-08-02 Zynerba Pharmaceuticals Inc Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas
AU2014225052B2 (en) 2013-03-08 2016-11-10 Nanjing Sanhome Pharmaceutical Co., Ltd. Novel nucleoside phosphoramidate compound and use thereof
JP6589884B2 (ja) * 2014-11-11 2019-10-16 宇部興産株式会社 非水電解液及びそれを用いた蓄電デバイス
BR112018071518A2 (pt) * 2016-04-22 2019-02-19 Receptor Life Sciences, Inc. compostos medicinais à base de planta de ação rápida e suplementos nutricionais
WO2018096504A1 (en) * 2016-11-28 2018-05-31 Kalytera Therapeutics, Inc Cbd prodrugs, compositions, and methods of administering cbd and cbd prodrugs
CN107082789B (zh) 2017-03-06 2020-08-28 湖南理工学院 一种以含p(o)-oh类化合物与酚高效酯化制备有机磷酸酯类化合物的方法
CA3145109A1 (en) * 2019-06-24 2020-12-30 Diverse Biotech, Inc. Cannabinoid conjugate molecules
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021000054A1 (en) 2019-07-04 2021-01-07 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997095B1 (en) 2019-07-12 2025-02-12 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021062557A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
EP4065568A4 (en) 2019-11-26 2024-01-03 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021113958A1 (en) 2019-12-09 2021-06-17 Canopy Growth Corporation Cannabinoid derivatives
WO2021139739A1 (zh) 2020-01-08 2021-07-15 成都百裕制药股份有限公司 大麻二酚衍生物及其制备方法和在医药上的应用

Similar Documents

Publication Publication Date Title
JP2022540585A5 (enExample)
JP2022539400A5 (enExample)
JP2023505513A5 (enExample)
KR102916143B1 (ko) 케타민의 전구약물, 및 이의 조성물 및 용도
JP2022540434A5 (enExample)
JP2022539401A5 (enExample)
JP2022540432A5 (enExample)
JP2023503331A5 (enExample)
JP2022540586A5 (enExample)
JP2023503601A5 (enExample)
KR101767882B1 (ko) Ｓ１ｐ 조절자로서의 （티오）모르폴린 유도체
JP5820056B2 (ja) Ｃｅｔｐ阻害剤としてのシクロアルケニルアリール誘導体
JP2015516420A5 (enExample)
WO2004074297A1 (ja) アミノホスホン酸誘導体とその付加塩及びs1p受容体調節剤
JP2023503330A5 (enExample)
JP7777083B2 (ja) モノアシルグリセロールリパーゼ調節因子としてのアザスピロ環化合物
JP2022540433A5 (enExample)
CA2451393A1 (en) 2 pyrrolidone derivatives as prostanoid agonists
JP2017526614A5 (enExample)
JP4833998B2 (ja) アミン化合物及びその医薬用途
AU2005219562A1 (en) Amino acid derivatives
Rassukana et al. Diastereoselective cycloaddition of (S)-N-(1-phenylethylimino) trifluoropropionate and trifluoroethylphosphonate with diazomethane
JP2025527291A (ja) Ｌｐ－ＰＬＡ２阻害剤としてのジヒドロイミダゾピリミジノン化合物およびその使用
TW202233575A (zh) 用於治療與lpa受體活性相關的病狀的化合物及組合物
CL2021001698A1 (es) Derivados de n-(4-(oxazol-5-il)fenil)cromano-3-carboxamida y compuestos relacionados a manera de estimuladores de la producción de células precursoras de la retina para el tratamiento contra enfermedades neurorretinianas.